MelaFind

Watch this video on the benefits of early melanoma detection, and how Electro-Optical Sciences (symbol "MELA") is attacking the problem with MelaFind:

Electro-Optical Sciences, Joseph V. Gulfo, President & CEO at OneMedTV.

Melanoma Monday

http://finance.yahoo.com/news/ElectroOptical-Sciences-to-iw-15090912.html

My former girlfriend is a 10-year survivor of melanoma, so this Monday will have a special place in my heart. MelaFind is not only a worthy investment, but it is a life saver. It detects melanoma (both positive and negative readings) better than the best dermatologists in the world.

In fact, her dermatologist assured her that her mole was benign, but upon her exit, he noticed she was uneasy with the prognosis. He ordered a biopsy so "she could sleep at night." The biopsy revealed stage 2/stage 3 melanoma, and she was scheduled for surgery the next day. As the CEO of Electro Optical Science was quoted, "With melanoma, the paranoid survive".

A big shout out to Lisa C on her 10-year anniversary! And may you have many more 10-year anniversaries.

Michael Murphy's take on Dendreon

Murphy is a well-respected investor newsletter writer. His claim to fame was making the right call on biotech behemoths Amgen, Biogen, and Genentech (recently bought out by Roche).


http://seekingalpha.com/instablog/128006-michael-murphy/1133-dendreon-a-360-stock-or-is-that-too-low

He's obviously bullish on DNDN, but a peak into his newsletter reveals he's also bullish on MELA and ARNA.

Do your due diligence and good luck.

Disclosure: I am long DNDN and ARNA.